Global /India /Healthcare /Drug Manufacturers - General /BETA

Beta Drugs Ltd.

BETA

• NSE: BETA • Delayed

1,333.90INR 2.2%

14.13 USD

As of 20 June 2026, Beta Drugs Ltd. has a market cap of $139.6M USD, ranking #23327 globally and #1381 in India. It ranks #2099 in the Healthcare sector, and #755 in the Drug Manufacturers - General industry.

Global Rank

23327

Country Rank

1381

Sector Rank

2099

Industry Rank

755

Key Stats

Market Cap

$139.6MUSD

13.18B INR

Enterprise Value

$142.01MUSD

13.41B INR

Revenue (TTM)

$40.75MUSD

3.85B INR

EBITDA (TTM)

$7.86MUSD

741.83M INR

Net Income (TTM)

$4.39MUSD

414.68M INR

EBITDA Margin

19%

Profit Margin

11%

PE Ratio

33.0

PS Ratio

3.4

PB Ratio

6.0

EV/EBITDA

18.1

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

399

Founded

1985

Website

betadrugslimited.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.2%	-0.9%	12%	-13%	-30%	-16%	-29%	76%	607%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	BETA Beta Drugs Ltd Ordinary Shares ISIN: INE351Y01019 Shares Out.: Shares Outstanding: 10.095M¹ Shares Float: 1.888M² TV: TradingView: NSE: BETA SA: Stock Analysis: NSE: BETA YF: Yahoo Finance: BETA.NS GF: Google Finance: NSE: BETA BA: Barron's: BETA MS: Morningstar: XNSE: BETA	1,333.90 INR	TV: TradingView: NSE: BETA SA: Stock Analysis: NSE: BETA YF: Yahoo Finance: BETA.NS GF: Google Finance: NSE: BETA BA: Barron's: BETA MS: Morningstar: XNSE: BETA

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Beta Drugs Ltd.

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 32K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 13K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 11K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 8K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 7K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 7K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 546K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 392K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 258K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 228K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 204K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 196K%	15.1	United States

chevron_leftBack